arrow
Y

Yong Ma

the first affiliated hospital of harbin medical university
H指数:30
被引数:2,610

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinoma” [Free Radic. Biol. Med. 163 (2021) 141–152]

勘误:“The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinoma” [Free Radic. Biol. Med. 163 (2021) 141–152]

2025-09-110
OAAI
NNMT/1-MNA protects against hepatic ischemia-reperfusion injury through the AKT/FOXO1/ANGPT2/JNK axis

Yin, B.; Qian, B.; Yu, H.; Ke, S.; Li, Z.; Hua, Y.; Lu, S.; Wang, C.; Li, M.; Guo, S.; et al. NNMT/1-MNA通过AKT/FOXO1/ANGPT2/JNK轴保护 against 肝缺血再灌注损伤。Nat. Commun. 2025, 16, 4779. [Google Scholar] [CrossRef]

2025-05-220
OAAI
TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages

TMEM147通过调节胆固醇稳态,抑制铁死亡和促进肿瘤相关巨噬细胞的M2极化来加重HCC的进展

2023-10-2817
OAAI